Synonyms
- Creatine Phosphokinase, Total
Special Instructions
State patient's sex on the request form.
Expected Turnaround Time
Within 1 day
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Related Documents
Specimen Requirements
Specimen
Serum (preferred) or plasma
Volume
1 mL
Minimum Volume
0.7 mL (Note: This volume does not allow for repeat testing.)
Container
Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube. Do not use oxalate, EDTA, or citrate plasma.
Collection
Separate serum or plasma from cells. Avoid prolonged contact of serum or plasma with red cells.
Storage Instructions
Maintain specimen at room temperature.
Stability Requirements
Temperature | Period |
|---|---|
Room temperature | 14 days |
Refrigerated | 14 days |
Frozen | 14 days |
Freeze/thaw cycles | Stable x3 |
Patient Preparation
Avoid exercise before venipuncture. Increases may be anticipated in the immediate postoperative period following surgical procedures involving incision through muscle.
Causes for Rejection
Hemolysis
Test Details
Use
Test for acute myocardial infarct and for skeletal muscular damage; elevated in some patients with myxedema (hypothyroidism), malignant hyperthermia syndrome, and muscular dystrophy. CK is a marker for Duchenne muscular dystrophy, with elevations of 20 to 200 times normal.1 CK is increased in female carriers of this X-linked disease, and in muscular stress, in polymyositis, dermatomyositis, and with muscle trauma. Elevated in myocarditis. Documentation of postictal state (recent grand mal seizure). Extremely high values are seen in some instances of myositis and in the postictal state. CK may be elevated in a number of entities, including the eosinophilia-myalgia syndrome.2 Marked increases occur with rhabdomyolysis including that with cocaine intoxication.3 CK is sometimes increased with cerebrovascular accident. Malignancy (advanced) may show increased CK.4 Cardioversion with multiple shocks may release CK-MB and may result in a false-positive diagnosis of myocardial infarction.5 Low CK may reflect decreased muscle mass. It has been reported with a number of entities, including metastatic neoplasia, patients with steroid therapy, with alcoholic liver disease6 and with connective tissue diseases.7 Overnight bedrest may lower CK 10% to 20%.
Limitations
Intramuscular injections increase serum CK activity. Elevated following exercise. Normal at onset of acute MI unless the subject has been exercising or doing physical work. Elevation of CK following acute MI may not be observed until six or more hours after onset. CK returns to normal in approximately 48 to 72 hours after acute MI. Total CK can be normal in acute MI, when CK-MB is increased. Low CK does not rule out myositis in patients with the connective tissue diseases.7 Decreased with pregnancy.
Methodology
Kinetic − 340 nm spectrophotometric
Reference Interval
See table.
Age | Male (U/L) | Female (U/L) |
|---|---|---|
0 to 7 d | 59−1111 | 55−777 |
8 to 30 d | 51−168 | 37−151 |
1 m to 1 y | 57−301 | 50−263 |
2 to 12 y | 53−229 | 45−198 |
13 to 17 y | 53−446 | 32−182 |
18 to 50 y | 49−439 | 32−182 |
51 to 80 y | 41–331 | 32–182 |
>80 y | 30–208 | 26–161 |
Additional Information
High CK is found after trauma, surgery, and exercise; these entities may not be accompanied by elevation of CK-MB. To distinguish myoglobinuria from hemoglobinuria, serum CK and LD may be helpful. CK is normal with uncomplicated hemolysis but LD and LD1 usually are increased. When myoglobin is released, 40-fold elevation of CK may be anticipated with only moderate increase in serum LD and increased LD5.8
Footnotes
1. Rosalki SB. Serum enzymes in disease of skeletal muscle. Clin Lab Med. 1989 Dec; 9(4):767-781. 2686911
2. Kilbourne EM, Swygert LA, Philen RM, et al. Interim guidance on the eosinophilia-myalgia syndrome. Ann Intern Med. 1990 Jan 15; 112(2):85-87. 2153013
3. Roth D, Alarcón FJ, Fernández JA, Preston RA, Bourgoignie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med. 1988 Sep 15; 319(11):673-677. 3412385
4. Eng C, Skolnick AE, Come SE. Elevated creatine kinase and malignancy. Hosp Pract (Off Ed). 1990; 25(12):123,126,129-130. 2123205
5. O'Neill PG, Faitelson L, Taylor A, Puleo P, Roberts R, Pacifico A. Time course of creatine kinase release after termination of sustained ventricular dysrhythmias. Am Heart J. 1991 Sep; 122(3 Pt 1):709-714. 1877446
6. Nanji AA, Blank D. Low serum creatine kinase activity in patients with alcoholic liver disease. Clin Chem. 1981 Nov; 27(11):1954. 7296863
7. Wei N, Pavlidis N, Tsokos G, Elin RJ, Plotz PH. Clinical significance of low creatine phosphokinase values in patients with connective tissue diseases. JAMA. 1981 Oct 23-30; 246(17):1921-1923. 7288967
8. Faulkner WR. Update on myoglobinurias. Lab Report for Physicians. 1989; 11:91-92.
LOINC® Map
| Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
|---|---|---|---|---|---|---|
| 001362 | Creatine Kinase,Total | 2157-6 | 001362 | Creatine Kinase,Total | U/L | 2157-6 |
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf